Uma Shankar Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Uma Shankar Singh has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Rashmi Kushwaha
King George’s Medical University, Lucknow, India
5 shared publications - Wahid Ali
Department of Pathology, King George's Medical University, Lucknow, IND
5 shared publications - Anoop Kumar Verma
Department of Forensic Medicine & Toxicology, King George’s Medical University, Lucknow, India
4 shared publications - Sachil Kumar
Amity Institute of Forensic Sciences, Amity University, Noida, India
4 shared publications - Shailendra Prasad Verma
Department of Clinical Hematology, King George’s Medical University, Lucknow, India
3 shared publications - Anurag Singh
Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh, India
2 shared publications
Latest Publications
- Open Access
- 15 May 2025
- Published by Springer Nature in Egyptian Journal of Forensic Sciences
- Vol. 15 (1) , 1-10
Exploring the paradigm of miRNA and cardiac troponin I expression in prolonged post-mortem interval
Background: Accurate post-mortem interval (PMI) determination remains crucial in forensic investigations. Building on our previous findings of miRNA-378, miRNA-206, and miRNA-195 as potential PMI biomarkers, this study evaluates their efficacy in burn and electrocution cases. We incorporate cardiac troponin I (cTnI) to enhance estimation precision. This multi-biomarker approach aims to elucidate the combined potential of miRNA and protein-based indicators for PMI determinations across diverse causes of mortality, addressing the need for more robust estimation methods. These biomarkers were studied in human cardiac tissues of burn and electrocution cases which was maintained at room temperature. Enzyme-linked immunosorbent assay (ELISA) and Real-time, polymerase chain reaction (RT-PCR) was used for cTnI and miRNA analysis, respectively. Result: In electrocution cases, a marked decrease in miRNA and cardiac troponin I (cTnI) expression correlates with increasing post-mortem interval (PMI). Specifically, miRNA-195 exhibited a 4.13-fold reduction from 3.1805 ± 1.873 at 12 h to -0.769 ± 2.111 at 196 h, with significant changes noted between 24 and 48 h (p < 0.05). miRNA-206 displayed a 2.2-fold decline, with variability observed particularly between 12 and 72 h (p < 0.05). cTnI revealed a substantial decrease, reinforcing its utility as an early PMI marker for electrocution fatalities. In contrast, burn cases showed an even sharper decline in miRNA-195 (6.84-fold), indicating a higher sensitivity to tissue degradation, while cTnI exhibited a more stable decrease. This comparative analysis illuminates distinct degradation patterns among biomarkers, enhancing their efficacy in PMI identification. Conclusion: We combined miRNA expression levels and cTnI concentrations to improve the accuracy of PMI estimation. Thus, relevance of time-dependent variations in miRNAs and cTnI, is investigated and highlighted the approach for optimal design of biomarkers and analytical techniques for PMI estimation.
- 15 May 2025
- Published by Springer Nature in Egyptian Journal of Forensic Sciences
- Vol. 15 (1) , 1-10
Open AccessExploring the paradigm of miRNA and cardiac troponin I expression in prolonged post-mortem interval
Background: Accurate post-mortem interval (PMI) determination remains crucial in forensic investigations. Building on our previous findings of miRNA-378, miRNA-206, and miRNA-195 as potential PMI biomarkers, this study evaluates their efficacy in burn and electrocution cases. We incorporate cardiac troponin I (cTnI) to enhance estimation precision. This multi-biomarker approach aims to elucidate the combined potential of miRNA and protein-based indicators for PMI determinations across diverse causes of mortality, addressing the need for more robust estimation methods. These biomarkers were studied in human cardiac tissues of burn and electrocution cases which was maintained at room temperature. Enzyme-linked immunosorbent assay (ELISA) and Real-time, polymerase chain reaction (RT-PCR) was used for cTnI and miRNA analysis, respectively. Result: In electrocution cases, a marked decrease in miRNA and cardiac troponin I (cTnI) expression correlates with increasing post-mortem interval (PMI). Specifically, miRNA-195 exhibited a 4.13-fold reduction from 3.1805 ± 1.873 at 12 h to -0.769 ± 2.111 at 196 h, with significant changes noted between 24 and 48 h (p < 0.05). miRNA-206 displayed a 2.2-fold decline, with variability observed particularly between 12 and 72 h (p < 0.05). cTnI revealed a substantial decrease, reinforcing its utility as an early PMI marker for electrocution fatalities. In contrast, burn cases showed an even sharper decline in miRNA-195 (6.84-fold), indicating a higher sensitivity to tissue degradation, while cTnI exhibited a more stable decrease. This comparative analysis illuminates distinct degradation patterns among biomarkers, enhancing their efficacy in PMI identification. Conclusion: We combined miRNA expression levels and cTnI concentrations to improve the accuracy of PMI estimation. Thus, relevance of time-dependent variations in miRNAs and cTnI, is investigated and highlighted the approach for optimal design of biomarkers and analytical techniques for PMI estimation.
- 15 August 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (2) , 102493
Co-occurrence of hydatid cyst liver with acute myeloid leukaemia: A rare case report
- 15 August 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (2) , 102493
Co-occurrence of hydatid cyst liver with acute myeloid leukaemia: A rare case report
- Open Access
- 25 December 2022
- Published by Kharkiv Regional Public Organization - Culture of Health in International Journal of Science Annals
- Vol. 5 (1-2) , 31-37
Blast crisis in chronic myeloid leukemia: An immunophenotypic analysis
- 25 December 2022
- Published by Kharkiv Regional Public Organization - Culture of Health in International Journal of Science Annals
- Vol. 5 (1-2) , 31-37
Open AccessBlast crisis in chronic myeloid leukemia: An immunophenotypic analysis
- Open Access
- 12 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25884
Hyperlipidemia and Platelet Parameters: Two Sides of the Same Coin
Introduction: Hyperlipidemia is a disorder in which lipid and cholesterol levels in the blood are elevated. Diabetes, coronary heart disease, obesity, and hypertension are commonly linked to hyperlipidemia. Despite this, hyperlipidemia is a widely neglected illness, owing to its asymptomatic nature, ignorance of aberrant lipid profiles on screening, and economic issues in poor countries such as India. Platelets have been shown to have a role in the thrombus consequences of atheromatous damage in hyperlipidemic individuals by initiating and propagating atherosclerotic plaques. Platelets with bigger diameters are thought to be more metabolically, enzymatically, and functionally agile than platelets with lower sizes. In steady-state operation, these bigger platelets release more thromboxane B2 than regular platelets. Platelets with bigger sizes are more hemostatically active and hence have a higher chance of forming a thrombus and thromboembolism. The aim of this study was to compare the values of key platelet parameters and platelet function in hyperlipidemic patients with normal age and sex-matched controls. Material and methods: A total of 100 individuals were included in this study, with 68 cases of hyperlipidemia and 32 controls having normal lipid profiles. Platelet volume indices (PVI) such as platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR), plateletcrit (PCT), and platelet function (platelet aggregation with adenosine diphosphate, ADP) were compared between hyperlipidemia patients and age sex-matched controls with normal lipid profiles. Results: The cases had a statistically significant higher mean MPV (10.55 ± 1.81), PDW (14.93 ± 2.82), and P-LCR (30.97 ± 11.74) compared to mean MPV (9.35 ± 1.85), PDW (13.10 ± 2.60), and P-LCR (25.13 ± 12.23) of controls (p-value < 0.05). No significant difference was observed between the study group and control group with respect to mean PC and PCT (p-value > 0.05). In this study, there was a statistically significant increase noted in platelet aggregation percentage in hyperlipidemic patients than in the control group (42.03 ± 25.28 vs 31.25 ± 15.11) (p-value < 0.05). Conclusion: To conclude, platelet parameters are a significant, easy, and cost-effective method for predicting future acute episodes in hyperlipidemic patients that should be utilized more widely. To avoid vascular events, these individuals may require higher antiplatelet dosages and more rigorous hyperlipidemia therapy.
- 12 June 2022
- Published by Springer Nature in Cureus
- Vol. 14 (6) , e25884
Open AccessHyperlipidemia and Platelet Parameters: Two Sides of the Same Coin
Introduction: Hyperlipidemia is a disorder in which lipid and cholesterol levels in the blood are elevated. Diabetes, coronary heart disease, obesity, and hypertension are commonly linked to hyperlipidemia. Despite this, hyperlipidemia is a widely neglected illness, owing to its asymptomatic nature, ignorance of aberrant lipid profiles on screening, and economic issues in poor countries such as India. Platelets have been shown to have a role in the thrombus consequences of atheromatous damage in hyperlipidemic individuals by initiating and propagating atherosclerotic plaques. Platelets with bigger diameters are thought to be more metabolically, enzymatically, and functionally agile than platelets with lower sizes. In steady-state operation, these bigger platelets release more thromboxane B2 than regular platelets. Platelets with bigger sizes are more hemostatically active and hence have a higher chance of forming a thrombus and thromboembolism. The aim of this study was to compare the values of key platelet parameters and platelet function in hyperlipidemic patients with normal age and sex-matched controls. Material and methods: A total of 100 individuals were included in this study, with 68 cases of hyperlipidemia and 32 controls having normal lipid profiles. Platelet volume indices (PVI) such as platelet count (PC), mean platelet volume (MPV), platelet distribution width (PDW), platelet large cell ratio (P-LCR), plateletcrit (PCT), and platelet function (platelet aggregation with adenosine diphosphate, ADP) were compared between hyperlipidemia patients and age sex-matched controls with normal lipid profiles. Results: The cases had a statistically significant higher mean MPV (10.55 ± 1.81), PDW (14.93 ± 2.82), and P-LCR (30.97 ± 11.74) compared to mean MPV (9.35 ± 1.85), PDW (13.10 ± 2.60), and P-LCR (25.13 ± 12.23) of controls (p-value < 0.05). No significant difference was observed between the study group and control group with respect to mean PC and PCT (p-value > 0.05). In this study, there was a statistically significant increase noted in platelet aggregation percentage in hyperlipidemic patients than in the control group (42.03 ± 25.28 vs 31.25 ± 15.11) (p-value < 0.05). Conclusion: To conclude, platelet parameters are a significant, easy, and cost-effective method for predicting future acute episodes in hyperlipidemic patients that should be utilized more widely. To avoid vascular events, these individuals may require higher antiplatelet dosages and more rigorous hyperlipidemia therapy.
- Open Access
- 25 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23495
Hematological Changes in the Second Wave of SARS-CoV-2 in North India
COVID-19 is a rapidly spreading pandemic caused by SARS-CoV-2. India experienced a second wave peak in mid of April 2021, and it emerged as a medical crisis. This study was taken up to show if the hematological and peripheral blood changes can be used as a readily available tool to demarcate the patients needing ICU care so that the ICU can be utilized more prudently. One hundred reverse transcription-polymerase chain reaction (RT-PCR) confirmed cases of COVID-19, 50 each from ICU and non-ICU wards, were included in this observational study. At the time of admission blood sample was collected for evaluation of hematological parameters. We noted that 74% of patients admitted in ICU were males and 28% were more than 60 years of age. In ICU patients, the absolute neutrophil count (ANC) was significantly raised when compared to non-ICU cases (p=0.023). The nadir absolute lymphocyte count (ALC) was 0.11x109/L in ICU patients and 0.95x109/L in non-ICU patients. There was a significant increase in neutrophil-lymphocyte ratio (NLR; p<0.001) in ICU patients with a proposed cut-off value of 7.73. Platelet-lymphocyte ratio (PLR) was also raised in ICU patients; however, this increase was not significant (p= 0.623). The proposed cut-off value of PLR is 126.73. A significant reduction in a lymphocyte-monocyte ratio (LMR) was observed in ICU patients when compared to non-ICU cases (p<0.001). Thrombocytopenia was more commonly seen in ICU patients; however, this was not statistically significant. Viral-induced cytopathic effects like plasmacytoid lymphocytes with cytoplasmic granules, the presence of toxic changes in neutrophils, and large-sized platelets were commonly observed in ICU patients. Our results suggest that hematological parameters like ANC, absolute lymphocyte count (ALC), platelet count, NLR, PLR, and peripheral smear changes are simple assessment factors that can serve as indicators for the severity of COVID-19 and will demarcate the patients who need ICU-care. This will help in the judicious use of ICU facilities for patients who are actually in need.
- 25 March 2022
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e23495
Open AccessHematological Changes in the Second Wave of SARS-CoV-2 in North India
COVID-19 is a rapidly spreading pandemic caused by SARS-CoV-2. India experienced a second wave peak in mid of April 2021, and it emerged as a medical crisis. This study was taken up to show if the hematological and peripheral blood changes can be used as a readily available tool to demarcate the patients needing ICU care so that the ICU can be utilized more prudently. One hundred reverse transcription-polymerase chain reaction (RT-PCR) confirmed cases of COVID-19, 50 each from ICU and non-ICU wards, were included in this observational study. At the time of admission blood sample was collected for evaluation of hematological parameters. We noted that 74% of patients admitted in ICU were males and 28% were more than 60 years of age. In ICU patients, the absolute neutrophil count (ANC) was significantly raised when compared to non-ICU cases (p=0.023). The nadir absolute lymphocyte count (ALC) was 0.11x109/L in ICU patients and 0.95x109/L in non-ICU patients. There was a significant increase in neutrophil-lymphocyte ratio (NLR; p<0.001) in ICU patients with a proposed cut-off value of 7.73. Platelet-lymphocyte ratio (PLR) was also raised in ICU patients; however, this increase was not significant (p= 0.623). The proposed cut-off value of PLR is 126.73. A significant reduction in a lymphocyte-monocyte ratio (LMR) was observed in ICU patients when compared to non-ICU cases (p<0.001). Thrombocytopenia was more commonly seen in ICU patients; however, this was not statistically significant. Viral-induced cytopathic effects like plasmacytoid lymphocytes with cytoplasmic granules, the presence of toxic changes in neutrophils, and large-sized platelets were commonly observed in ICU patients. Our results suggest that hematological parameters like ANC, absolute lymphocyte count (ALC), platelet count, NLR, PLR, and peripheral smear changes are simple assessment factors that can serve as indicators for the severity of COVID-19 and will demarcate the patients who need ICU-care. This will help in the judicious use of ICU facilities for patients who are actually in need.
- Open Access
- 26 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5567
Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
Background: Cardiac troponin is the best marker to diagnose acute coronary syndrome (ACS). However, early diagnosis using markers for plaque instability may be of significance. Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) plays an important role in the pathogenesis of atherosclerosis plaque rupture and may be a potential biomarker of coronary artery disease (CAD), including ACS. The current study aims to evaluate sLOX-1 levels in the sera of patients with ACS as an independent marker of CAD with other established diagnostic markers and assess its level before and after percutaneous intervention (PCI) in predicting the risk of future recurrence of ACS. Methods: Peripheral blood was obtained from a total of 160 patients, including patients who underwent coronary angiography (n = 18, group I), patients of stable CAD who underwent percutaneous intervention (n = 50, group II), patients of the acute coronary syndrome (n = 64, group III), and healthy controls (n = 28, group IV). A serum sLOX-1 concentration was measured by the enzyme-linked immunosorbent assay (ELISA). Results: The results obtained showed a statistically significant raised level of sLOX-1 in pre/post PCI patients of stable CAD/ACS with male preponderance. The area under the curve for sLOX-1 was 0.925 for cases that are discriminated from controls with sensitivity and specificity of 87.88 and 100%, respectively. SLOX-1 showed 100% sensitivity and specificity in the discrimination of the stable CAD that underwent PCI vs. control with an AUC of 1.00. The recurrence of coronary artery disease was observed in 9 out of 132 (6.8%) cases. The post-interventional sLOX-1 level was significantly different and higher in recurrent cases (p = 0.027) of ACS/CAD. Conclusions: sLOX-1 was a useful biomarker of stable CAD/ACS and has a potential in the risk prediction of a future recurrence of coronary artery disease.
- 26 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5567
Open AccessCirculating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
Background: Cardiac troponin is the best marker to diagnose acute coronary syndrome (ACS). However, early diagnosis using markers for plaque instability may be of significance. Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) plays an important role in the pathogenesis of atherosclerosis plaque rupture and may be a potential biomarker of coronary artery disease (CAD), including ACS. The current study aims to evaluate sLOX-1 levels in the sera of patients with ACS as an independent marker of CAD with other established diagnostic markers and assess its level before and after percutaneous intervention (PCI) in predicting the risk of future recurrence of ACS. Methods: Peripheral blood was obtained from a total of 160 patients, including patients who underwent coronary angiography (n = 18, group I), patients of stable CAD who underwent percutaneous intervention (n = 50, group II), patients of the acute coronary syndrome (n = 64, group III), and healthy controls (n = 28, group IV). A serum sLOX-1 concentration was measured by the enzyme-linked immunosorbent assay (ELISA). Results: The results obtained showed a statistically significant raised level of sLOX-1 in pre/post PCI patients of stable CAD/ACS with male preponderance. The area under the curve for sLOX-1 was 0.925 for cases that are discriminated from controls with sensitivity and specificity of 87.88 and 100%, respectively. SLOX-1 showed 100% sensitivity and specificity in the discrimination of the stable CAD that underwent PCI vs. control with an AUC of 1.00. The recurrence of coronary artery disease was observed in 9 out of 132 (6.8%) cases. The post-interventional sLOX-1 level was significantly different and higher in recurrent cases (p = 0.027) of ACS/CAD. Conclusions: sLOX-1 was a useful biomarker of stable CAD/ACS and has a potential in the risk prediction of a future recurrence of coronary artery disease.
- 1 October 2015
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 35, 29-32
Autopsy audit of intentional burns inflicted by self or by others in north India-5 year snapshot
- 1 October 2015
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 35, 29-32
Autopsy audit of intentional burns inflicted by self or by others in north India-5 year snapshot
- 1 August 2015
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 34, 45-49
The effect of elapsed time on cardiac troponin-T (cTnT) degradation and its relation to postmortem interval in cases of electrocution
- 1 August 2015
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 34, 45-49
The effect of elapsed time on cardiac troponin-T (cTnT) degradation and its relation to postmortem interval in cases of electrocution